Non-medical use of prescription drugs #NonMedicalDrugs


Ian Hamilton and Julia Buxton from the University of York preview the #NonMedicalDrugs event that will take place in York on Friday 16th March 2018.

The meeting will bring together people who can offer personal and professional insights of the extent of the issue and how we can support people who develop problems.

[read the full story...]

Off-label antidepressants: limited evidence to support their use


John Baker reports on Canadian study looking at prescriptions of off-label antidepressants in primary care, which concludes that when antidepressants were used outside of their licence, there was usually not strong evidence supporting the respective indication.

[read the full story...]

Psychotropic medication: finding ways forward for adults with intellectual disabilities #RSMpsychotropics


Rory Sheehan and Angela Hassiotis discuss how to optimise psychotropic medication for people with intellectual disabilities; the theme of their #RSMpsychotropics conference taking place in London today.

[read the full story...]

People’s experiences of taking antidepressants


Alison Faulkner reflects on the findings of a qualitative study from New Zealand that explores users’ diverse experiences of taking antidepressants.

[read the full story...]

Antipsychotic overprescribing in people with learning disabilities #UCLJournalClub


Tayla McCloud from the #UCLJournalClub presents the findings of a cohort study showing that antipsychotics are being over-prescribed in people with learning disabilities.

[read the full story...]

Self-harm in primary care: more prescribing than referrals

Screen Shot 2015-12-14 at 12.49.41

Olivia Kirtley and Alys Cole-King present a major new cohort study, which includes worrying evidence about the clinical management of patients in primary care following self-harm.

[read the full story...]

Proton-pump inhibitors and risk of dementia


Caroline Struthers reports on a recent prospective cohort study which finds a strong association between the use of proton pump inhibitors and a significantly increased risk of dementia.

[read the full story...]